123 related articles for article (PubMed ID: 37209494)
1. Do classical and computerized cognitive tests have equal intrarater reliability in myotonic dystrophy type 1?
Fortin J; Côté I; Gagnon C; Gallais B
Neuromuscul Disord; 2023 Jun; 33(6):490-497. PubMed ID: 37209494
[TBL] [Abstract][Full Text] [Related]
2. Frontostriatal dysexecutive syndrome: a core cognitive feature of myotonic dystrophy type 2.
Peric S; Mandic-Stojmenovic G; Stefanova E; Savic-Pavicevic D; Pesovic J; Ilic V; Dobricic V; Basta I; Lavrnic D; Rakocevic-Stojanovic V
J Neurol; 2015 Jan; 262(1):142-8. PubMed ID: 25346064
[TBL] [Abstract][Full Text] [Related]
3. Cognitive Decline and White Matter Integrity Degradation in Myotonic Dystrophy Type I.
Lopez-Titla MM; Chirino A; Cruz Solis SV; Hernandez-Castillo CR; Diaz R; Márquez-Quiroz LDC; Magaña JJ; Beltrán-Parrazal L; Fernandez-Ruiz J
J Neuroimaging; 2021 Jan; 31(1):192-198. PubMed ID: 32936994
[TBL] [Abstract][Full Text] [Related]
4. Comparing Web-Based and Lab-Based Cognitive Assessment Using the Cambridge Neuropsychological Test Automated Battery: A Within-Subjects Counterbalanced Study.
Backx R; Skirrow C; Dente P; Barnett JH; Cormack FK
J Med Internet Res; 2020 Aug; 22(8):e16792. PubMed ID: 32749999
[TBL] [Abstract][Full Text] [Related]
5. Association between Neuropsychological Performance and CSF Profile in Subjective Cognitive Decline: Towards the Diagnosis of Preclinical AD.
Chipi E; Bellomo G; Salvadori N; Montanucci C; Gaetani L; Paolini Paoletti F; Parnetti L
J Prev Alzheimers Dis; 2023; 10(3):523-529. PubMed ID: 37357293
[TBL] [Abstract][Full Text] [Related]
6. Age-related cognitive decline in myotonic dystrophy type 1: An 11-year longitudinal follow-up study.
Labayru G; Aliri J; Zulaica M; López de Munain A; Sistiaga A
J Neuropsychol; 2020 Mar; 14(1):121-134. PubMed ID: 31407859
[TBL] [Abstract][Full Text] [Related]
7. Does the Cambridge Automated Neuropsychological Test Battery (CANTAB) Distinguish Between Cognitive Domains in Healthy Older Adults?
Lenehan ME; Summers MJ; Saunders NL; Summers JJ; Vickers JC
Assessment; 2016 Apr; 23(2):163-72. PubMed ID: 25882162
[TBL] [Abstract][Full Text] [Related]
8. Cognitive phenotype of childhood myotonic dystrophy type 1: A multicenter pooled analysis.
Sweere DJJ; Moelands SVL; Klinkenberg S; Leenen L; Hendriksen JGM; Braakman HMH
Muscle Nerve; 2023 Jul; 68(1):57-64. PubMed ID: 37129457
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and correlates of apathy in myotonic dystrophy type 1.
Gallais B; Montreuil M; Gargiulo M; Eymard B; Gagnon C; Laberge L
BMC Neurol; 2015 Aug; 15():148. PubMed ID: 26296336
[TBL] [Abstract][Full Text] [Related]
10. Brief assessment of cognitive function in myotonic dystrophy: Multicenter longitudinal study using computer-assisted evaluation.
Deutsch GK; Hagerman KA; Sampson J; Dent G; Dekdebrun J; Parker DM; Thornton CA; Heatwole CR; Subramony SH; Mankodi AK; Ashizawa T; Statland JM; Arnold WD; Moxley RT; Day JW;
Muscle Nerve; 2022 May; 65(5):560-567. PubMed ID: 35179228
[TBL] [Abstract][Full Text] [Related]
11. Cognition in myotonic dystrophy type 1: a 5-year follow-up study.
Winblad S; Samuelsson L; Lindberg C; Meola G
Eur J Neurol; 2016 Sep; 23(9):1471-6. PubMed ID: 27323306
[TBL] [Abstract][Full Text] [Related]
12. Cognitive decline over time in adults with myotonic dystrophy type 1: A 9-year longitudinal study.
Gallais B; Gagnon C; Mathieu J; Richer L
Neuromuscul Disord; 2017 Jan; 27(1):61-72. PubMed ID: 27919548
[TBL] [Abstract][Full Text] [Related]
13. Cognitive assessment in patients with myotonic dystrophy type 2.
Peric S; Gunjic I; Delic N; Stojiljkovic Tamas O; Salak-Djokic B; Pesovic J; Petrovic Djordjevic I; Ivanovic V; Savic-Pavicevic D; Meola G; Rakocevic-Stojanovic V
Neuromuscul Disord; 2022 Sep; 32(9):743-748. PubMed ID: 35879188
[TBL] [Abstract][Full Text] [Related]
14. Distinctive Pattern of Cognitive Disorders During Multiple Sclerosis Relapse and Recovery Based on Computerized CANTAB Tests.
Giedraitiene N; Kaubrys G
Front Neurol; 2019; 10():572. PubMed ID: 31214108
[No Abstract] [Full Text] [Related]
15. Characterizing cognitive-motor impairments in patients with myotonic dystrophy type 1.
Filli L; Schwegler S; Meyer C; Killeen T; Easthope CS; Broicher SD; Curt A; Zörner B; Bolliger M; Jung HH; Petersen JA
Neuromuscul Disord; 2020 Jun; 30(6):510-520. PubMed ID: 32527589
[TBL] [Abstract][Full Text] [Related]
16. Assessment of neuropsychological performance in Mexico City youth using the Cambridge Neuropsychological Test Automated Battery (CANTAB).
Green R; Till C; Al-Hakeem H; Cribbie R; Téllez-Rojo MM; Osorio E; Hu H; Schnaas L
J Clin Exp Neuropsychol; 2019 Apr; 41(3):246-256. PubMed ID: 30336715
[TBL] [Abstract][Full Text] [Related]
17. Using the Cambridge Neuropsychological Test Automated Battery (CANTAB) to assess the cognitive impact of electroconvulsive therapy on visual and visuospatial memory.
Falconer DW; Cleland J; Fielding S; Reid IC
Psychol Med; 2010 Jun; 40(6):1017-25. PubMed ID: 19775495
[TBL] [Abstract][Full Text] [Related]
18. Examining 3-month test-retest reliability and reliable change using the Cambridge Neuropsychological Test Automated Battery.
Karlsen RH; Karr JE; Saksvik SB; Lundervold AJ; Hjemdal O; Olsen A; Iverson GL; Skandsen T
Appl Neuropsychol Adult; 2022; 29(2):146-154. PubMed ID: 32083946
[TBL] [Abstract][Full Text] [Related]
19. Feasibility and Validity of Cambridge Neuropsychological Test Automated Battery in Mild Cognitive Impairment Screening for Patients with Atrial Fibrillation.
Wang J; Lai Y; Jiang C; Bai Y; Xu B; Du X; Dong J; Ma C
Comput Math Methods Med; 2022; 2022():1527292. PubMed ID: 35178112
[TBL] [Abstract][Full Text] [Related]
20. Evidence of practice effect in CANTAB spatial working memory test in a cohort of patients with mild cognitive impairment.
Cacciamani F; Salvadori N; Eusebi P; Lisetti V; Luchetti E; Calabresi P; Parnetti L
Appl Neuropsychol Adult; 2018; 25(3):237-248. PubMed ID: 28631988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
